Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp (TCNNF) provides comprehensive medical and recreational cannabis products through its vertically integrated operations across multiple U.S. states. This news hub offers investors and stakeholders direct access to official corporate announcements, financial disclosures, and operational updates.
Discover timely information about earnings reports, regulatory compliance milestones, dispensary expansions, and product innovations. Our curated collection ensures transparent tracking of Trulieve's market leadership in cultivation practices and retail operations within strictly regulated environments.
Key updates include strategic acquisitions, new market entries, sustainability initiatives, and advancements in medical cannabis research. All content originates from verified company communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of TCNNF's operational developments and industry positioning. Check regularly for updates on one of the cannabis sector's most influential multi-state operators.
On April 28, 2022, Trulieve Cannabis Corp. announced that CEO Kim Rivers received the Women's Leadership Award from Green Market Report for her contributions in the cannabis industry. Rivers has driven significant business advancements, including leading retail expansion and the acquisition of Harvest Health. Trulieve also released its first ESG report, marking a milestone in corporate responsibility. The award ceremony took place during the Women's Summit in New York City, highlighting the importance of female leadership in the cannabis sector.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the completion of its acquisition of Greenhouse Wellness West Virginia Dispensaries LLC, which holds a dispensary permit in West Virginia. The acquisition, covered by the West Virginia Department of Health and Human Resources, involved a minimal cash payment. This deal enhances Trulieve's presence in West Virginia, where it now operates ten dispensaries in key locations and plans to open more in the near future. CEO Kim Rivers emphasized the company's commitment to community investment and improved patient access to high-quality products.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Zephyrhills, Florida on April 16, 2022. This dispensary aims to enhance patient access and features grand opening specials, including a 25% discount for registered patients. Trulieve is the leading medical cannabis provider in Florida, offering a wide range of THC and CBD products. The company emphasizes personalized patient care and support through trained retail employees. For more details on Trulieve's operations and other locations, visit trulieve.com.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Fort Myers, Florida, on April 13, 2022. The dispensary, located at 15620 Summerlin Rd, will feature grand opening festivities, including giveaways, food trucks, and a 25% discount for registered patients. As a leading medical cannabis provider, Trulieve offers a diverse range of THC and CBD products in Florida, with a focus on personalized patient care through trained staff. The company aims to build community relationships while expanding access to medical cannabis.
Trulieve Cannabis Corp. has opened its third dispensary in Framingham, Massachusetts on April 3, 2022. This new, 5,000 square foot location aims to provide an elevated in-store experience with a contemporary design. Initially serving adult-use customers, the dispensary will also cater to medical cannabis patients later this Spring. A grand opening celebration is set for April 9, 2022, featuring celebrity appearances and promotional offers. Trulieve continues to expand its footprint in Massachusetts, enhancing customer access to a variety of cannabis products.
Trulieve Cannabis Corp. (OTCQX: TCNNF) has announced its participation in multiple conferences in April 2022, highlighting strategic engagement with investors. CEO Kim Rivers will lead discussions at the BTIG Global Cannabis Conference on April 6, the Cantor Virtual Cannabis Conference on April 14, and the Benzinga Cannabis Capital Conference on April 20, along with a speech at The Green Market Report's Women's Summit on April 28. Trulieve operates in 11 states, focusing on growth in retail and distribution, particularly in Arizona, Florida, and Pennsylvania.
Trulieve Cannabis Corp. announces an exclusive partnership with DeLisioso LLC to produce and sell the Flamingo Kush pre-rolls in Florida, starting April 15, 2022. DeLisioso, founded by Richard DeLisi, focuses on high-end cannabis products and aims to support families affected by the War on Drugs. The partnership allows Trulieve to expand its product offerings as the leading cannabis provider in Florida. Flamingo Kush, an indica-dominant strain, will be available in all Trulieve dispensaries, showcasing DeLisioso's commitment to quality and social impact.
Trulieve Cannabis Corp. announced the launch of adult-use sales at its Harvest dispensary in Napa, California, starting April 1, 2022. This location is among the first to offer adult-use cannabis following the City Council's approval of a new ordinance on February 1. Harvest of Napa, recognized as the "Best Dispensary" three times by Bohemian Magazine, offers over 90 strains of flower. The company is expanding its retail footprint in California, emphasizing tailored experiences for local communities.
Trulieve Cannabis Corp. announced a record revenue of $938.4 million for 2021, representing an 80% increase year-over-year. The quarterly revenue for Q4 2021 reached $305.3 million, up 36% sequentially. Despite the strong revenue growth, the company experienced a decline in gross margin to 60.3% from 74.1% in 2020, primarily due to diversification into lower-margin markets. Net income for 2021 was $18.0 million, with an adjusted EBITDA of $384.6 million. Trulieve anticipates revenue between $1.3 billion to $1.4 billion for 2022.
